Suppr超能文献

治疗老年女性和卵巢早衰女性卵巢性不孕、睾丸性不孕及其他人类功能性疾病的新方法。

Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases.

作者信息

Bukovsky Antonin

机构信息

The Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

出版信息

Reprod Biol Endocrinol. 2015 Feb 25;13:10. doi: 10.1186/s12958-015-0001-8.

Abstract

In vitro maturation (IVM) and in vitro fertilization (IVF) technologies are facing with growing demands of older women to conceive. Although ovarian stem cells (OSCs) of older women are capable of producing in vitro fresh oocyte-like cells (OLCs), such cells cannot respond to IVM and IVF due to the lack of granulosa cells required for their maturation. Follicular renewal is also dependent on support of circulating blood mononuclear cells. They induce intermediary stages of meiosis (metaphase I chromosomal duplication and crossover, anaphase, telophase, and cytokinesis) in newly emerging ovarian germ cells, as for the first time demonstrated here, induce formation of granulosa cells, and stimulate follicular growth and development. A pretreatment of OSC culture with mononuclear cells collected from blood of a young healthy fertile woman may cause differentiation of bipotential OSCs into both developing germ and granulosa cells. A small blood volume replacement may enable treatment of ovarian infertility in vivo. The transferred mononuclear cells may temporarily rejuvenate virtually all tissues, including improvement of the function of endocrine tissues. Formation of new follicles and their development may be sufficient for IVM and IVF. The novel proposed in vitro approaches may be used as a second possibility. Infertility of human males affects almost a half of the infertility cases worldwide. Small blood volume replacement from young healthy fertile men may also be easy approach for the improvement of sperm quality in older or other affected men. In addition, body rejuvenation by small blood volume replacement from young healthy individuals of the same sex could represent a decline of in vitro methodology in favor of in vivo treatment for human functional diseases. Here we propose for the first time that blood mononuclear cells are essential for rejuvenation of those tissues, where immune system components participate in an appropriate division and differentiation of tissue stem cells. If needed, small blood volume replacement from distinct young healthy individuals could be utilized in six month intervals for repair of young altered or aged reproductive and other tissue functions. Systemic and local use of honey bee propolis tincture is an alternative option for functional rejuvenation of some tissues.

摘要

体外成熟(IVM)和体外受精(IVF)技术正面临着老年女性日益增长的受孕需求。尽管老年女性的卵巢干细胞(OSCs)能够在体外产生新鲜的卵母细胞样细胞(OLCs),但由于缺乏其成熟所需的颗粒细胞,这些细胞无法对IVM和IVF产生反应。卵泡更新也依赖于循环血单核细胞的支持。正如本文首次证明的那样,它们诱导新出现的卵巢生殖细胞进入减数分裂的中间阶段(中期I染色体复制和交叉、后期、末期和胞质分裂),诱导颗粒细胞形成,并刺激卵泡生长和发育。用从年轻健康可育女性血液中收集的单核细胞对OSC培养物进行预处理,可能会使双能OSCs分化为发育中的生殖细胞和颗粒细胞。少量血液置换可能有助于体内治疗卵巢性不孕。转移的单核细胞可能会暂时使几乎所有组织恢复活力,包括改善内分泌组织的功能。新卵泡的形成及其发育可能足以进行IVM和IVF。所提出的新的体外方法可能是第二种选择。男性不育影响着全球几乎一半的不孕病例。从年轻健康可育男性进行少量血液置换,对于改善老年或其他受影响男性的精子质量也可能是一种简便方法。此外,从年轻健康的同性个体进行少量血液置换来实现身体年轻化,可能意味着体外方法的减少,转而支持针对人类功能性疾病的体内治疗。我们首次提出,血液单核细胞对于那些免疫系统成分参与组织干细胞适当分裂和分化的组织的年轻化至关重要。如有需要,可每隔六个月从不同的年轻健康个体进行少量血液置换,以修复年轻受损或老化的生殖及其他组织功能。全身和局部使用蜜蜂蜂胶酊是一些组织功能年轻化的另一种选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验